OncoSynergy

Stamford, United States

OncoSynergy improves outcomes for patients with unmet needs in oncology with resistance mechanism inhibitors.

May 2026

Venture - Series Unknown

Top Investors

Connecticut InnovationsKorea Information & Communication Co.NLabs

19,000+ verified contacts

Emails, phones & LinkedIn profiles

Who are OncoSynergy's investors?

OncoSynergy's investors include Connecticut Innovations, Korea Information & Communication Co., NLabs.

Where is OncoSynergy headquartered?

OncoSynergy is headquartered in Stamford, United States.

What does OncoSynergy do?

OncoSynergy improves outcomes for patients with unmet needs in oncology with resistance mechanism inhibitors.

What stage is OncoSynergy at?

OncoSynergy is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 26, 2026.

MLA

"OncoSynergy — Funding & Investors." VCBacked, May 26, 2026, https://www.vcbacked.co/company/oncosynergy. Accessed June 3, 2026.

APA

VCBacked. (2026). OncoSynergy — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/oncosynergy

Wikipedia (cite web)

{{cite web |title=OncoSynergy — Funding & Investors |url=https://www.vcbacked.co/company/oncosynergy |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 26, 2026.